A uroplakin subtype that heterodimerizes with UROPLAKIN IA to form a component of the asymmetric unit membrane found in urothelial cells.
Uroplakin Ii has been studied across 12 research domains including 🔬 Oncology, ⏳ Longevity & Aging, 🫘 Kidney, 🧠 Learning, 🛡️ Immunity. The primary research focus is 🔬 Oncology with 57% of studies addressing this area.
This evidence profile for Uroplakin Ii is generated deterministically from 129 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.